This partnership marks the first step in CILCARE’s strategy to build technological alliances around Synapound AI™, its clinical analytics platform
Montpellier, France, November 9, 2026 – CILCARE, a biotech company pioneering auditory science, is taking a new step forward in harnessing auditory data through a strategic partnership with SONUP, a specialist in innovative hearing assessment solutions. The first in a series of technological alliances initiated by CILCARE, this agreement aims to enhance the collection and analysis of auditory data, notably through remote monitoring, with the goal of accelerating the development of new treatments.
Auditory data: a new driver of clinical research
The quality and depth of data have become critical to clinical research in audiology. Accurately characterizing patients’ hearing abilities, monitoring changes over time and correlating these measurements with other biomarkers are now among the key challenges in the field. This is an area in which CILCARE is making significant progress, leveraging Synapsound AI™ and partnering with leading innovators in auditory data collection technologies.
SONUP brings its technological and audiological expertise in the design of innovative hearing tests and assessment protocols, enabling in-depth evaluation of hearing abilities, particularly speech-in-noise comprehension and binaural hearing. Its tools can be used independently and remotely.
CILCARE contributes its expertise in clinical research in neurotology, its know-how in developing drug candidates to treat hearing loss and tinnitus, as well as its capabilities in clinical data analysis.
The partnership will focus on two main areas:
- Integrating SONUP’s solutions into specific research protocols conducted by CILCARE, in accordance with the objectives of each clinical study;
- Jointly designing and validating new hearing tests tailored to the specific needs of clinical research in audiology
A first step in CILCARE’s data strategy
This partnership marks the beginning of a series of alliances that CILCARE plans to establish with technology players in hearing assessment and digital health. The aim is to bring together complementary data sources, which will be integrated and analysed through Synapsound AI™, to support both CILCARE’s own programs and those of its industrial and academic partners. Further joint projects with SONUP are already under consideration.
A partnership rooted in Montpellier
Both headquartered in Montpellier, France, SONUP and CILCARE illustrate the dynamism of the region’s healthcare innovation ecosystem.
“With SONUP’s highly innovative solutions, patients can perform hearing tests at home, independently. Combined with SYNAPSOUND AI™, our clinical analytics platform, these data can be processed more rapidly and cross-referenced with other biomarkers, thereby contributing to the advancement of precision medicine. This partnership is the first in a series of collaborations: our ambition is to make auditory data a true driver of therapeutic development,” says ジェローム・ジョフロワ, Chief Digital Officer at CILCARE.
“This partnership represents a great opportunity to put our expertise at the service of clinical research. Our tests and technologies now make it possible to explore hearing in greater depth and with high reliability, even through self-administered assessments, which is precisely what makes this collaboration so valuable. By working with CILCARE’s teams, we will be able to assess our solutions against new clinical needs while also jointly developing new assessment methods. It is this complementarity between our respective areas of expertise that makes this collaboration particularly exciting,” says Maxime BALCON, CEO of SONUP.
This agreement marks the beginning of a collaboration set to grow through future research projects, as well as the first step in a broader partnership strategy that CILCARE intends to pursue.
About CILCARE: Cilcare is a biopharmaceutical company pioneering auditory science, with expertise in drugs and diagnostics designed to prevent and treat hearing disorders. Built on deep auditory neuroscience capabilities, Cilcare supports preclinical and clinical development for its own pipeline and for industrial and academic partners worldwide. Headquartered in Montpellier, France, with subsidiaries in Boston, MA and Tokyo, Cilcare operates across Europe, USA, and Asia. More information: www.cilcare.com
About SONUP: Founded in 2019 in Montpellier, SONUP specializes in the design and development of hearing tests, which it markets through innovative digital solutions or integrates directly into existing audiometer models. Its technologies are mainly intended for healthcare professionals and research organizations, but also for companies and the broader healthcare sector as part of hearing health awareness initiatives. More information: www.sonup.fr
Download the Press Release:
Contacts
CILCARE : Marie PEYTAVY / marie.peytavy@cilcare.com / +33 7 69 74 19 05
SONUP : Diane CRUNELLE / diane.c@sonup.fr
